Glenmark Pharma Share Price History & Returns (2000 To 2026)
Share Price HistoryGLENMARK FinancialsTomorrow TargetLong Term TargetDividend HistoryBonus HistorySplit History
Show Table of Contents
Table of Contents
- 1: Glenmark Pharma Share Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Glenmark Pharma Recent Performance
- 3: Glenmark Pharma Share Price Chart From 2000 to 2026
- 4: Glenmark Pharma Share Price History Table From 2000 to 2026
- 5: Analyzing the Impact of Investing in Glenmark Pharma
- 5.1: Glenmark Pharma Share Returns In Last 5 Years
- 5.2: Glenmark Pharma Share Returns In Last 10 Years
- 5.3: Glenmark Pharma Share Returns In Last 15 Years
- 5.4: Glenmark Pharma Share Returns In Last 20 Years
- 6: Glenmark Pharma Returns vs Bank FD Returns
- 7: Short Info About Glenmark Pharma
- 7.1: Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
- 7.2: Additional Resources
Glenmark Pharma Share Highlights
As of Mon 15 Jun 2026, Glenmark Pharma Share price is ₹2,156.6 which is ₹317.40 below 52-week high of ₹2,474 and ₹531.60 above 52-week low of ₹1,625
52-Week High Low
- Glenmark Pharma 52-Week High is ₹2,474
- Glenmark Pharma 52-Week Low is ₹1,625 occurred on Fri 20 Jun 2025
All Time High
- The all-time high or the highest price that Glenmark Pharma shares have ever touched was ₹2,471.19 and this occurred on Oct 2024.
- The highest closing price at which Glenmark Pharma shares have ever closed was ₹2,426.1 recorded on Aug 2024.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Glenmark Pharma Recent Performance
Over the past 15 trading days, the value of Glenmark Pharma's stock has decreased by ₹180.40 (-7.72%).
From 25 May 2026 to 15 Jun 2026, it reached a high of ₹2,400.70 and a low of ₹2,117.00.
Glenmark Pharma Share Price Chart From 2000 to 2026
Glenmark Pharma Share Price History Table From 2000 to 2026
| Year | Glenmark Pharma | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2026 | ₹2,173.8 | 6.8% |
↑ ₹2,474 ↓ ₹1,842 |
| 2025 | ₹2,035.2 | 26.5% |
↑ ₹2,284.8 ↓ ₹1,275.5 |
| 2024 | ₹1,609.1 | 88.4% |
↑ ₹1,830.95 ↓ ₹771 |
| 2023 | ₹853.95 | 101.3% |
↑ ₹880 ↓ ₹369.05 |
| 2022 | ₹424.15 | -19.8% |
↑ ₹531.2 ↓ ₹348.5 |
| 2021 | ₹528.54 | 7.1% |
↑ ₹690.95 ↓ ₹442.05 |
| 2020 | ₹493.5 | 42.0% |
↑ ₹573.04 ↓ ₹161.65 |
| 2019 | ₹347.45 | -49.9% |
↑ ₹697.6 ↓ ₹267.25 |
| 2018 | ₹693.05 | 16.5% |
↑ ₹711.9 ↓ ₹493.5 |
| 2017 | ₹594.75 | -33.1% |
↑ ₹972.95 ↓ ₹525.85 |
| 2016 | ₹888.45 | -3.6% |
↑ ₹994 ↓ ₹671.1 |
| 2015 | ₹921.9 | 19.7% |
↑ ₹1,262.9 ↓ ₹702.6 |
| 2014 | ₹770.2 | 44.3% |
↑ ₹841 ↓ ₹496.1 |
| 2013 | ₹533.85 | 1.0% |
↑ ₹613.35 ↓ ₹458 |
| 2012 | ₹528.54 | 80.1% |
↑ ₹550.7 ↓ ₹285 |
| 2011 | ₹293.55 | -18.9% |
↑ ₹372.2 ↓ ₹241.1 |
| 2010 | ₹362.1 | 31.3% |
↑ ₹389.9 ↓ ₹233.35 |
| 2009 | ₹275.85 | -6.8% |
↑ ₹311.5 ↓ ₹119.2 |
| 2008 | ₹296.1 | -50.3% |
↑ ₹736 ↓ ₹211.1 |
| 2007 | ₹596 | 295.5% |
↑ ₹624 ↓ ₹123.25 |
| 2006 | ₹150.68 | 92.2% |
↑ ₹371.4 ↓ ₹56.5 |
| 2005 | ₹78.39 | 29.3% |
↑ ₹310.25 ↓ ₹54.72 |
| 2004 | ₹60.61 | 238.8% |
↑ ₹143.47 ↓ ₹15.88 |
| 2003 | ₹17.89 | 1,390.8% |
↑ ₹71.78 ↓ ₹1 |
| 2002 | ₹1.2 | -87.3% |
↑ ₹1.45 ↓ ₹0.93 |
| 2001 | ₹9.46 | -7.3% |
↑ ₹11.74 ↓ ₹4.53 |
| 2000 | ₹10.21 | - |
↑ ₹16.2 ↓ ₹9.4 |
Analyzing the Impact of Investing in Glenmark Pharma
Glenmark Pharma share price in 2000 was ₹10.21. If you had invested ₹10,000 in Glenmark Pharma shares in 2000, in 26 years, your investment would have grown to ₹21.29 Lakh by 2026. This represents a positive return of 21,190.9% with a CAGR of 22.9%.
Glenmark Pharma Share Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹2,474.00 and lowest was: ₹348.50
- Glenmark Pharma Share price in 2022 was ₹424.15
- By 2026, its share price rose to ₹2,173.80
- It gave a positive return of 412.5% with a CAGR of 38.7% over the last 5 years
- If you had invested ₹10,000 in Glenmark Pharma in 2022 then in 5 years, your investment would have grown to ₹51,250.73 by 2026
Glenmark Pharma Share Returns In Last 10 Years
- Its highest stock price in the last 10 years was: ₹2,474.00 and lowest was: ₹161.65
- Glenmark Pharma Share price in 2017 was ₹594.75
- By 2026, its share price rose to ₹2,173.80
- It gave a positive return of 265.5% with a CAGR of 13.8% over the last 10 years
- If you had invested ₹10,000 in Glenmark Pharma in 2017 then in 10 years, your investment would have grown to ₹36,549.81 by 2026
Glenmark Pharma Share Returns In Last 15 Years
- Its highest stock price in the last 15 years was: ₹2,474.00 and lowest was: ₹161.65
- Glenmark Pharma Share price in 2012 was ₹528.55
- By 2026, its share price rose to ₹2,173.80
- It gave a positive return of 311.3% with a CAGR of 9.9% over the last 15 years
- If you had invested ₹10,000 in Glenmark Pharma in 2012 then in 15 years, your investment would have grown to ₹41,127.61 by 2026
Glenmark Pharma Share Returns In Last 20 Years
- Its highest stock price in the last 20 years was: ₹2,474.00 and lowest was: ₹119.20
- Glenmark Pharma Share price in 2007 was ₹596.00
- By 2026, its share price rose to ₹2,173.80
- It gave a positive return of 264.7% with a CAGR of 6.7% over the last 20 years
- If you had invested ₹10,000 in Glenmark Pharma in 2007 then in 20 years, your investment would have grown to ₹36,473.15 by 2026
Glenmark Pharma Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Glenmark Pharma Shares | ₹10,000 | ₹21.29 Lakh | 21,190.9% |
| Bank FD (Simple Interest) | ₹10,000 | ₹25,600 | 156.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹45,493.82 | 354.9% |
Short Info About Glenmark Pharma
Glenmark Pharmaceuticals: A Global Pharmaceutical Leader Established in 1977, Glenmark Pharmaceuticals has emerged as a prominent player in the global pharmaceutical industry. Headquartered in Mumbai, India, the company possesses a substantial market presence across multiple regions, including North America, Latin... Read More
Glenmark Pharmaceuticals: A Global Pharmaceutical Leader
Established in 1977, Glenmark Pharmaceuticals has emerged as a prominent player in the global pharmaceutical industry. Headquartered in Mumbai, India, the company possesses a substantial market presence across multiple regions, including North America, Latin America, Europe, Japan, and international markets.
Glenmark's diversified product range encompasses both branded and generic formulations, specializing in therapeutic areas such as dermatology, respiratory, and oncology.
- Branded Formulations: Glenmark offers a portfolio of innovative branded products, including Ryaltris nasal spray for seasonal allergic rhinitis.
- Generic Formulations: The company's generic formulations provide affordable access to essential medicines in various therapeutic categories.
- Active Pharmaceutical Ingredients: Glenmark manufactures a range of active pharmaceutical ingredients, serving as a key supplier to the global pharmaceutical market.
Glenmark's commitment to innovation and research is evident in its robust product pipeline, which includes several promising drug candidates in Phase 1 and 2 clinical trials.
The company's reputation for excellence and customer focus has garnered widespread recognition within the pharmaceutical industry, solidifying its position as a reliable and trusted partner in healthcare.
Additional Resources
For more insights into Glenmark Pharma, explore these resources:
